Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
Article
Google Scholar
Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–54.
Article
CAS
Google Scholar
Raungrut P, Wongkotsila A, Lirdprapamongkol K, Svasti J, Geater SL, Phukaoloun M, Suwiwat S, Thongsuksai P. Prognostic significance of 14-3-3gamma overexpression in advanced non-small cell lung cancer. Asian Pac J Cancer Prev. 2014;15(8):3513–8.
Article
Google Scholar
Thomas A, Liu SV, Subramaniam DS, Giaccone G. Refining the treatment of NSCLC according to histological and molecular subtypes. Nat Rev Clin Oncol. 2015. https://doi.org/10.1038/nrclinonc.2015.90.
Article
PubMed
Google Scholar
Hellmann MD, Ciuleanu TE, Pluzanski A, Lee JS, Otterson GA, Audigier-Valette C, Minenza E, Linardou H, Burgers S, Salman P. Nivolumab plus Ipilimumab in lung cancer with a high tumor mutational burden. N Engl J Med. 2018. https://doi.org/10.1056/NEJMoa1801946.
Article
PubMed
PubMed Central
Google Scholar
Li B, Severson E, Pignon JC, Zhao H, Liu XS. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17(1):174.
Article
Google Scholar
Rooney MS, Shukla SA, Wu CJ, Getz G, Hacohen N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell. 2015;160(1–2):48–61.
Article
CAS
Google Scholar
Shinya K, Keiju A, Genichiro I, Shoko N, Takashi S. Prognostic impact of the number of metastatic lymph nodes on the eighth edition of the TNM classification of non-small cell lung cancer. J Thorac Oncol. 2019;14:1408–18.
Article
Google Scholar
Maria B, Stefano S, Maurizio M, Silvana G, Antonella V, Anita S, Fabrizio L, Anna C. Heterogeneity of PD-L1 expression and relationship with biology of NSCLC. Anticancer Res. 2018;38(7):3789–96.
Article
Google Scholar
Warth A, Muley T, Herpel E, Meister M, Schnabel PA. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. Histopathology. 2012;61(6):1017–25.
Article
Google Scholar
Song C, Wu Z, Wang Q, Wang Y, Hu W. A combined two-mRNA signature associated with PD-L1 and tumor mutational burden for prognosis of lung adenocarcinoma. Front Cell Dev Biol. 2021. https://doi.org/10.3389/fcell.2021.634697.
Article
PubMed
PubMed Central
Google Scholar
Sun J, Zhang Z, Bao S, Yan C, Hou P, Wu N, Su J, Xu L, Zhou M. Identification of tumor immune infiltration-associated lncRNAs for improving prognosis and immunotherapy response of patients with non-small cell lung cancer. J Immunother Cancer. 2020. https://doi.org/10.1136/jitc-2019-000110.
Article
PubMed
PubMed Central
Google Scholar
Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W. Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J Surg Oncol. 2011;104(7):847–51.
Article
CAS
Google Scholar
Bense RD, Christos S, Piccart-Gebhart MJ, Haanen JBAG, van Vugt MATM, De Vries EGE, Schrder CP, Fehrmann RSN. Relevance of tumor-infiltrating immune cell composition and functionality for disease outcome in breast cancer. JNCI J Natl Cancer Inst. 2016. https://doi.org/10.1093/jnci/djw192.
Article
PubMed
Google Scholar
Barnes TA, Amir E. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer. Br J Cancer. 2017. https://doi.org/10.1038/bjc.2017.220.
Article
PubMed
PubMed Central
Google Scholar
Stankovic B, Bjrhovde HAK, Skarshaug R, Aamodt H, Frafjord A, Müller E, Hammarstrm C, Beraki K, Bkkevold ES, Woldbk PR. Immune cell composition in human non-small cell lung cancer. Front Immunol. 2018;9:3101.
Article
CAS
Google Scholar
Ponten F, Jirstrom K, Uhlen M. The Human Protein Atlas—a tool for pathology. J Pathol. 2008;216(4):387–93.
Article
CAS
Google Scholar
Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW, Levine DA, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.
Article
Google Scholar
Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–7.
Article
CAS
Google Scholar
Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572–3.
Article
CAS
Google Scholar
Therneau TM, Lumley T. Package ‘survival.’ R Top Doc. 2015;128(10):28–33.
Google Scholar
Kassambara A, Kosinski M, Biecek P, Fabian S. Package ‘survminer’. 2017.
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.
Article
Google Scholar
Consortium GO. Gene Ontology annotations and resources. J Nucleic Acids Res. 2012;41(D1):D530–5.
Article
Google Scholar
Wickham H. ggplot2. Wiley Interdiscip Rev Comput Stat. 2011;3(2):180–5.
Article
Google Scholar
Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinform. 2014;15(1):1–7.
Article
Google Scholar
Shi J, Walker M. Gene set enrichment analysis (GSEA) for interpreting gene expression profiles. Curr Bioinform. 2007;2(2):133–7.
Article
CAS
Google Scholar
Ranstam J, Cook J. LASSO regression. J Br Surg. 2018;105(10):1348–1348.
Article
Google Scholar
Sullivan LM, Massaro JM, D’Agostino Sr RB. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23(10):1631–60.
Article
Google Scholar
Harrell Jr FE, Harrell Jr MFE, Hmisc D. Package ‘rms’. 2017, 229.
Kerr KF, Brown MD, Zhu K, Janes H. Assessing the clinical impact of risk prediction models with decision curves: guidance for correct interpretation and appropriate use. J Clin Oncol. 2016;34(21):2534–40.
Article
Google Scholar
Blanche P, Blanche MP. Package ‘timeROC’. 2019.
Gridelli C, Peters S, Sgambato A. ALK inhibitors in the treatment of advanced NSCLC. Cancer Treat Rev. 2014;40(2):300–6.
Article
CAS
Google Scholar
Skoulidis F, Heymach JV. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. Nat Rev Cancer. 2019;19(6411):495–509.
Article
CAS
Google Scholar
Seo JS, Kim A, Shin JY, Kim YT. Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor. Sci Rep. 2018. https://doi.org/10.1038/s41598-018-32855-8.
Article
PubMed
PubMed Central
Google Scholar
Biase SD, Ma X, Wang X, Yu J, Wang YC, Smith DJ, Zhou Y, Li Z, Kim YJ, Clarke N. Creatine uptake regulates CD8 T cell antitumor immunity. J Exp Med. 2019. https://doi.org/10.1084/jem.20182044.
Article
PubMed
PubMed Central
Google Scholar
Kim HC, Choi CM. Current status of immunotherapy for lung cancer and future perspectives. Tuberc Respir Dis. 2020. https://doi.org/10.4046/trd.2019.0039.
Article
Google Scholar
Wu F, Li GZ, Liu HJ, Zhao Z, Chai RC, Liu YQ, Jiang HY, Zhai Y, Feng YM. Molecular subtyping reveals immune alterations in IDH wild-type lower-grade diffuse glioma. J Pathol. 2020. https://doi.org/10.1002/path.5468.
Article
PubMed
PubMed Central
Google Scholar
Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 1996;7(1):93–102.
Article
CAS
Google Scholar
Inoue T, Ishida T, Takenoyama M, Sugio K, Sugimachi K. The relationship between the immunodetection of transforming growth factor-β in lung adenocarcinoma and longer survival rates. Surg Oncol. 1995;4(1):51–7.
Article
CAS
Google Scholar
De Rosa V, Iommelli F, Monti M, Fonti R, Votta G, Stoppelli MP, Del Vecchio S. Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non-small cell lung cancer. Clin Cancer Res. 2015;21:5110–20.
Article
Google Scholar
Ou SI, Ziogas A, Zell JA. Epidemiology study of never-smokers with non-small cell lung cancer (NSCLC): high percentages of Asian and Hispanic female never-smokers and the significance of Asian ethnicity. J Clin Oncol. 2008;26(15_suppl):8004–8004.
Article
Google Scholar
Schumacher K, Haensch W, Roefzaad C, Schlag PM. Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res. 2001;61(10):3932–6.
CAS
PubMed
Google Scholar
Naito Y, Saito K, Shiiba K, Ohuchi A, Saigenji K, Nagura H, Ohtani H. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 1998;58(16):3491–4.
CAS
PubMed
Google Scholar
Nakakubo Y, Miyamoto M, Cho Y, Hida Y, Oshikiri T, Suzuoki M, Hiraoka K, Itoh T, Kondo S, Katoh H. Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer. 2003;89(9):1736–42.
Article
CAS
Google Scholar
Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. The central role of CD4+ T cells in the antitumor immune response. J Exp Med. 1998;188(12):2357–68.
Article
CAS
Google Scholar
Hiraoka K, Miyamoto M, Cho Y, Suzuoki M, Oshikiri T, Nakakubo Y, Itoh T, Ohbuchi T, Kondo S, Katoh H. Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer. 2006;94(2):275–80.
Article
CAS
Google Scholar